Showing results (4081-4090 of 5,227) with videos related to

Sort By:
Pageof 523
Antiviral Research|September 22, 2021
An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviralJustin G Julander, James F Demarest, Ray Taylor, et al.
Antiviral Research|March 12, 2022
Label-free duplex SAMDI-MS screen reveals novel SARS-CoV-2 3CLpro inhibitorsMichael D Scholle, Patrick T O'Kane, Sandra Dib, et al.
Antiviral Research|March 12, 2022
A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitorsK Y Chen, T Krischuns, L Ortega Varga, et al.
Antiviral Research|March 8, 2022
In vitro and in vivo efficacy of a novel nucleoside analog H44 against Crimean-Congo hemorrhagic fever virusQianran Wang, Ruiyuan Cao, Liushuai Li, et al.
Antiviral Research|February 23, 1999
Emergence of resistance to acyclovir and penciclovir in varicella-zoster virus and genetic analysis of acyclovir-resistant variantsM Ida, S Kageyama, H Sato, et al.
Antiviral Research|February 23, 1999
The S-acyl-2-thioethyl pronucleotide approach applied to acyclovir: part I. Synthesis and in vitro anti-hepatitis B virus activity of bis(S-acyl-2-thioethyl)phosphotriester derivatives of acyclovirC Périgaud, G Gosselin, J L Girardet, et al.
Antiviral Research|May 13, 1999
Inhibition of HIV-1 replication by newly developed adamantane-containing polyanionic agentsM E Burstein, A V Serbin, T V Khakhulina, et al.
Antiviral Research|May 13, 1999
A phase I trial of the pharmacokinetics, toxicity, and activity of KNI-272, an inhibitor of HIV-1 protease, in patients with AIDS or symptomatic HIV infectionR W Humphrey, K M Wyvill, B Y Nguyen, et al.
Antiviral Research|May 13, 1999
A high throughput colorimetric cell proliferation assay for the identification of human cytomegalovirus inhibitorsJ Bedard, S May, D Barbeau, et al.
Antiviral Research|September 21, 2000
Small molecule inhibitor of HIV-1 nuclear import suppresses HIV-1 replication in human lymphoid tissue ex vivo: a potential addition to current anti-HIV drug repertoireS Glushakova, L Dubrovsky, J Grivel, et al.
Pageof 523